Conjugation of two complementary anti-cancer drugs confers molecular hydrogels as a co-delivery system†
Abstract
We reported in this communication on the first example of a molecular hydrogel system based on two complementary anti-cancer
Maintenance work is planned for Wednesday 1st May 2024 from 9:00am to 11:00am (BST).
During this time, the performance of our website may be affected - searches may run slowly and some pages may be temporarily unavailable. If this happens, please try refreshing your web browser or try waiting two to three minutes before trying again.
We apologise for any inconvenience this might cause and thank you for your patience.
* Corresponding authors
a
State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300071, P. R. China
E-mail:
yangzm@nankai.edu.cn
b Key Laboratory of Bioactive Materials, Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, P. R. China
We reported in this communication on the first example of a molecular hydrogel system based on two complementary anti-cancer
L. Mao, H. Wang, M. Tan, L. Ou, D. Kong and Z. Yang, Chem. Commun., 2012, 48, 395 DOI: 10.1039/C1CC16250K
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content